Rafferty Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Sell |
32,196
-12,389
| -28% | -$4.04M | 0.03% | 260 |
|
|
2025
Q1 | $12M | Sell |
44,585
-8,232
| -16% | -$2.22M | 0.05% | 226 |
|
|
2024
Q4 | $12.4M | Sell |
52,817
-11,014
| -17% | -$2.59M | 0.04% | 249 |
|
|
2024
Q3 | $17.6M | Sell |
63,831
-17,279
| -21% | -$4.75M | 0.06% | 170 |
|
|
2024
Q2 | $19.7M | Buy |
81,110
+19,904
| +33% | +$4.84M | 0.07% | 146 |
|
|
2024
Q1 | $9.15M | Buy |
61,206
+8,398
| +16% | +$1.26M | 0.03% | 295 |
|
|
2023
Q4 | $10.1M | Buy |
52,808
+8,640
| +20% | +$1.65M | 0.04% | 276 |
|
|
2023
Q3 | $7.82M | Buy |
44,168
+615
| +1% | +$109K | 0.05% | 290 |
|
|
2023
Q2 | $8.27M | Buy |
43,553
+5,362
| +14% | +$1.02M | 0.05% | 257 |
|
|
2023
Q1 | $7.65M | Buy |
38,191
+1,888
| +5% | +$378K | 0.05% | 256 |
|
|
2022
Q4 | $8.63M | Buy |
36,303
+3,411
| +10% | +$811K | 0.07% | 229 |
|
|
2022
Q3 | $6.58M | Buy |
32,892
+1,702
| +5% | +$341K | 0.07% | 244 |
|
|
2022
Q2 | $4.55M | Sell |
31,190
-5,845
| -16% | -$852K | 0.04% | 295 |
|
|
2022
Q1 | $6.05M | Buy |
37,035
+5,090
| +16% | +$831K | 0.04% | 326 |
|
|
2021
Q4 | $5.42M | Buy |
31,945
+15,515
| +94% | +$2.63M | 0.03% | 360 |
|
|
2021
Q3 | $3.1M | Buy |
16,430
+621
| +4% | +$117K | 0.02% | 457 |
|
|
2021
Q2 | $2.68M | Sell |
15,809
-7,619
| -33% | -$1.29M | 0.02% | 549 |
|
|
2021
Q1 | $3.31M | Buy |
23,428
+16,239
| +226% | +$2.29M | 0.02% | 424 |
|
|
2020
Q4 | $934K | Sell |
7,189
-9,017
| -56% | -$1.17M | 0.01% | 520 |
|
|
2020
Q3 | $2.36M | Buy |
16,206
+6,263
| +63% | +$912K | 0.03% | 368 |
|
|
2020
Q2 | $1.47M | Buy |
9,943
+5,863
| +144% | +$869K | 0.02% | 434 |
|
|
2020
Q1 | $444K | Sell |
4,080
-29,417
| -88% | -$3.2M | 0.02% | 357 |
|
|
2019
Q4 | $3.86M | Sell |
33,497
-44,138
| -57% | -$5.08M | 0.06% | 172 |
|
|
2019
Q3 | $6.24M | Buy |
77,635
+6,858
| +10% | +$551K | 0.1% | 121 |
|
|
2019
Q2 | $5.14M | Buy |
70,777
+11,052
| +19% | +$802K | 0.09% | 160 |
|
|
2019
Q1 | $5.58M | Buy |
+59,725
| New | +$5.58M | 0.09% | 120 |
|